Abstract

Drug-target interaction (DTI) is a key aspect in pharmaceutical research. With the ever-increasing new drug data resources, computational approaches have emerged as powerful and labor-saving tools in predicting new DTIs. However, so far, most of these predictions have been based on structural similarities rather than biological relevance. In this study, we proposed for the first time a “GO and KEGG enrichment score” method to represent a certain category of drug molecules by further classification and interpretation of the DTI database. A benchmark dataset consisting of 2,015 drugs that are assigned to nine categories ((1) G protein-coupled receptors, (2) cytokine receptors, (3) nuclear receptors, (4) ion channels, (5) transporters, (6) enzymes, (7) protein kinases, (8) cellular antigens and (9) pathogens) was constructed by collecting data from KEGG. We analyzed each category and each drug for its contribution in GO terms and KEGG pathways using the popular feature selection “minimum redundancy maximum relevance (mRMR)” method, and key GO terms and KEGG pathways were extracted. Our analysis revealed the top enriched GO terms and KEGG pathways of each drug category, which were highly enriched in the literature and clinical trials. Our results provide for the first time the biological relevance among drugs, targets and biological functions, which serves as a new basis for future DTI predictions.

Highlights

  • Drug-target interaction (DTI) studies are of great importance for drug research and development (R&D), as they give rise to a better understanding of how drug molecules interact with their targets and predict possible adverse drug reactions (ADRs)

  • We obtained a dataset S consisting of 2,015 drug compounds that were classified into nine target-based classes: (1) G Protein-coupled receptors (GPCRs), (2) Cytokine receptors (CRs), (3) Nuclear receptors (NRs), (4) Ion channels (ICs), (5) T, (6) E, (7) Protein kinases (PKs), (8) Cellular antigens (CAs), and (9) P

  • Ps include a wide range of infectious agents, such as a virus, bacterium, prion, fungus or protozoan [43]. Their top enriched functions are hsa04080 neuroactive ligand-receptor interaction, but the level values are low (1.75 and 0.87). These results suggest that these drugs share the same class of targets, they vary in biological functions due to different enriched pathways

Read more

Summary

Introduction

Drug-target interaction (DTI) studies are of great importance for drug research and development (R&D), as they give rise to a better understanding of how drug molecules interact with their targets and predict possible adverse drug reactions (ADRs). Statistics have revealed a significant decrease in the rate that new drug candidates are translated into effective therapies in the clinic [1], and drug repositioning has grown in importance. PLOS ONE | DOI:10.1371/journal.pone.0126492 May 7, 2015

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call